市場調査レポート
商品コード
1076184

内視鏡再処理の世界市場:製品別 (HLD・試験紙、洗浄剤・ワイプ、内視鏡自動再処理装置 (AER)、内視鏡乾燥・保管・搬送システム、追跡ソリューション)・エンドユーザー別 (病院、ASC・クリニック) の将来予測 (2022年~2027年)

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 - 2027)

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 259 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
内視鏡再処理の世界市場:製品別 (HLD・試験紙、洗浄剤・ワイプ、内視鏡自動再処理装置 (AER)、内視鏡乾燥・保管・搬送システム、追跡ソリューション)・エンドユーザー別 (病院、ASC・クリニック) の将来予測 (2022年~2027年)
出版日: 2022年05月11日
発行: MarketsandMarkets
ページ情報: 英文 259 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の内視鏡再処理の市場規模は、2022年の24億米ドルから、2027年までに38億米ドルに達すると予測されています。

また、2022年から2027年までのCAGRは9.7%となる見通しです。市場の主な促進要因として、内視鏡検査のニーズ拡大や、内視鏡の汚染による感染リスクの高さ、再処理ガイドラインの改定、医療インフラ・内視鏡の研究向け投資・助成金の増額などが挙げられます。

製品別では、高レベル消毒剤 (HLD)・試験紙のセグメントが最大のシェアを獲得しています。エンドユーザー別では、病院が最大のセグメントとなっています。地域別に見ると、北米が最大の市場となる見通しです。

当レポートでは、世界の内視鏡再処理の市場について分析し、市場の基本構造や最新情勢、主な市場促進・抑制要因、市場動向の見通し、製品別・エンドユーザー別・地域別の詳細動向、市場競争の状態、主要企業のプロファイルなどを調査しております。

目次

第1章 イントロダクション

第2章 分析方法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概略

  • イントロダクション
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 課題
  • 新型コロナウイルス感染症 (COVID-19) 感染拡大:影響分析
  • 範囲/シナリオ
  • 規制分析
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • バリューチェーン分析
  • エコシステム分析
  • 技術分析
  • 主要な会議とイベント (2022年~2023年)
  • 特許分析
  • 貿易分析
  • 価格分析
  • 主要な利害関係者と購入基準
  • 顧客のビジネスに影響を与える傾向/ディスラプション

第6章 内視鏡再処理市場:製品別

  • イントロダクション
  • 高レベル消毒剤 (HLD)・試験紙
  • 洗剤・ワイプ
  • 内視鏡自動再処理装置 (AER)
    • 可搬性別
    • 種類別
  • 内視鏡乾燥・保管・搬送システム
  • 内視鏡追跡システム
  • その他の製品

第7章 内視鏡再処理市場:エンドユーザー別

  • イントロダクション
  • 病院
  • 外来手術センター (ASC)・クリニック
  • その他のエンドユーザー

第8章 内視鏡再処理市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • 他の欧州諸国
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 他のアジア太平洋諸国
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第9章 競合情勢

  • 概要
  • 主要企業の戦略/市場獲得戦略
  • 収益分析
  • 市場シェア分析
  • 企業の評価クアドラント (主要企業)
  • 競合リーダーシップマッピング (スタートアップ・中小企業)
  • 企業のフットプリント
  • 競合シナリオと動向
    • 資本取引
    • 製品の発売と承認
    • 事業拡張

第10章 企業プロファイル

  • 主要企業
    • CANTEL MEDICAL
    • ADVANCED STERILIZATION PRODUCTS (FORTIVE)
    • OLYMPUS CORPORATION
    • ECOLAB
    • STERIS
    • GETINGE AB
    • WASSENBURG MEDICAL (HOYAのメンバー)
    • CONMED CORPORATION
    • BELIMED AG (METALL ZUG GROUPの子会社)
    • ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL)
    • CUSTOM ULTRASONICS
    • STEELCO S.P.A
    • BES HEALTHCARE (BES REHAB LTDの一部)
    • ARC HEALTHCARE SOLUTIONS
    • METREX RESEARCH, LLC
  • その他の企業
    • RICHARD WOLF GMBH
    • MEDALKAN
    • MICRO-SCIENTIFIC, LLC
    • BORER CHEMIE AG
    • MEDONICA CO. LTD
    • TUTTNAUER
    • ATMS
    • SUMMIT IMAGING, INC.
    • SHINVA MEDICAL INSTRUMENT CO., LTD
    • MEDICAL DEVICES GROUP SRL

第11章 付録

目次
Product Code: MD 5654

The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to iIncreasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during the forecast period.

"High-level disinfectants and test stripsare expected to hold the largest share of the endoscope reprocessing market, by product in 2021."

Based on product, the global endoscope reprocessing market is segmented into high-level disinfectants and test strips; detergents & wipes; endoscope tracking systems; endoscope drying, storage, and transport systems; automated endoscope reprocessors (AERs); and other products (brushes and flushing aids, leak testers, hookups, and sponges). In 2021, the high-level disinfectants and test strips segment holds the largest share of the global endoscope reprocessing market. The large share of this segment is due to outbreak of infectious diseases to drive high-level disinfectants demand. Test strips are used to effectively measure the minimum recommended concentration of high-level disinfectants and provide fast disinfectant reaction time and a user-friendly color comparison chart to detect residual carbohydrate, protein, and hemoglobin to monitor the success of endoscope cleaning procedures.

"Hospitals are expected to hold the largest share of the endoscope reprocessing market, by end user in 2021."

Based on end users, the global endoscope reprocessing market is segmented into hospitals, ambulatory surgery centers and clinics, and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy centers). In 2021, the hospitals' segment has the largest share due to large patient volume in hospitals related to endoscopic procedures leads to increase demand for endoscope reprocessing products in hospitals.

"North America commanded the largest share of the endoscope reprocessing market in 2021."

Based on region, the endoscope reprocessing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America has the largest share of the endoscope reprocessing market. The largest share of North America can be attributed to factors such as the rising number of cancer cases, favorable reimbursement scenarios, and Increasing requirement for endoscopy to diagnose and treat target diseases.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (20%), Tier 2(45%), and Tier 3 (35%)
  • By Designation: C-level Executives (30%), Directors (20%), and Others (50%)
  • By Region: North America (33%), Europe (24%), AsiaPacific(27%), and Rest of the World (16%)

Some of the major players operating in this market areAdvanced Sterilization Products(US), Olympus Corporation (Japan), Ecolab(US), and STERIS(Ireland)

List of Companies Profiled in the Report

  • Cantel Medical (US)
  • Advanced Sterilization Products (ASP) (US)
  • Olympus Corporation (Japan)
  • Ecolab (US)
  • STERIS (Ireland)
  • Getinge AB (Sweden)
  • Wassenburg Medical (Netherlands)
  • CONMED Corporation (US)
  • Belimed AG (Switzerland)
  • Endo-Technik W. Griesat (Germany)
  • Custom Ultrasonics (US)
  • Steelco S.p.A. (Italy)
  • BES Healthcare Ltd (UK)
  • ARC Healthcare Solutions (Canada)
  • Metrex Research, LLC. (Canada)
  • Richard Wolf GmbH (Germany)
  • MEDALKAN (Greece)
  • Micro-Scientific, LLC (US)
  • Borer Chemie AG (Switzerland)
  • Tuttnauer (Netherlands)
  • ATMS (Canada)
  • Summit Imaging, Inc. (US)
  • Medonica Co. LTD (South Korea)
  • SHINVA MEDICAL INSTRUMENT CO. LTD (China)
  • Medical Devices Group Srl (Italy)

Research Coverage

This report studies the endoscope reprocessing market based on product, end user, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total endoscope reprocessing market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on endoscope reprocessingoffered by the top 25 players in the endoscope reprocessing market. The report analyzes the endoscope reprocessing marketproduct, end user,and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devicesacross key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the endoscope reprocessing market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the endoscope reprocessing market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 GEOGRAPHIC SCOPE
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION: BELIMED AG (A METALL ZUG GROUP COMPANY).
    • FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF ENDOSCOPE REPROCESSING PRODUCTS AND SERVICES
    • FIGURE 7 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
    • FIGURE 8 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 STUDY ASSUMPTIONS
  • 2.5 RISK ASSESSMENT/FACTOR ANALYSIS
    • TABLE 1 RISKS

3 EXECUTIVE SUMMARY

    • FIGURE 10 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2022 VS. 2027 (USD BILLION)
    • FIGURE 11 ENDOSCOPE REPROCESSING MARKET, BY END-USER, 2022 VS. 2027 (USD BILLION)
    • FIGURE 12 ENDOSCOPE REPROCESSING MARKET, BY REGION, 2022 VS. 2027 (USD BILLION)

4 PREMIUM INSIGHTS

  • 4.1 ENDOSCOPE REPROCESSING MARKET OVERVIEW
    • FIGURE 13 RISING INCIDENCE OF TARGET DISEASES AND SUBSEQUENT INCREASE IN ENDOSCOPIC PROCEDURES TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SHARE, BY PRODUCT (2021)
    • FIGURE 14 HIGH-LEVEL DISINFECTANTS AND TEST STRIPS SEGMENT TO DOMINATE MARKET IN 2021
  • 4.3 GEOGRAPHICAL SNAPSHOT OF ENDOSCOPE REPROCESSING MARKET
    • FIGURE 15 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 ENDOSCOPE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing requirement for endoscopy to diagnose and treat target diseases
      • 5.2.1.2 High risk of endoscope-associated infections
      • 5.2.1.3 Growing geriatric population and subsequent increase in endoscopic procedures
      • 5.2.1.4 Increasing emphasis on improving reprocessing guidelines by healthcare authorities
      • 5.2.1.5 Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy
    • TABLE 2 MAJOR DEVELOPMENTS
      • 5.2.1.6 Increasing preference for minimally invasive surgeries
      • 5.2.1.7 Rising focus of medical specialists and healthcare providers on shifting from manual to automated endoscopy reprocessing
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Concerns related to reprocessed instrument safety
      • 5.2.2.2 Adverse effects of chemical disinfectants
      • 5.2.2.3 High overhead costs of endoscopy procedures with limited reimbursement in developing countries
      • 5.2.2.4 High risk of COVID-19 transmission during endoscopic procedures
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing medical devices industry in emerging economies
    • FIGURE 17 MEDICAL DEVICES MARKET, 2016-2020 (USD BILLION)
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Preference for single-use endoscopes
      • 5.2.4.2 Increasing number of product failures and recalls
      • 5.2.4.3 Shortage of trained professionals
      • 5.2.4.4 Lack of awareness associated with reprocessing methods
      • 5.2.4.5 Increasing FDA recommended measures to reduce infection transmission
  • 5.3 COVID-19 IMPACT ANALYSIS
    • FIGURE 18 PERCENTAGE OF ENDOSCOPY PROCEDURES/PER WEEK BEFORE AND DURING COVID-19
  • 5.4 RANGES/ SCENARIOS
    • 5.4.1 ENDOSCOPE REPROCESSING MARKET
    • FIGURE 19 REALISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET
    • FIGURE 20 PESSIMISTIC SCENARIO OF THE ENDOSCOPE REPROCESSING MARKET
    • FIGURE 21 OPTIMISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET
  • 5.5 REGULATORY ANALYSIS
    • TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICE REPROCESSING
    • 5.5.1 NORTH AMERICA
      • 5.5.1.1 US
    • FIGURE 22 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR REPROCESSED MEDICAL DEVICES
      • 5.5.1.2 Canada
    • TABLE 4 CANADA: REPROCESSING POLICIES OF SINGLE-USE MEDICAL DEVICES
    • 5.5.2 EUROPE
    • FIGURE 23 CE MARKING FOR REPROCESSED MEDICAL DEVICES
      • 5.5.2.1 Germany
      • 5.5.2.2 Rest of Europe
    • 5.5.3 ASIA PACIFIC
      • 5.5.3.1 Japan
      • 5.5.3.2 Australia
      • 5.5.3.3 Rest of Asia Pacific
    • 5.5.4 LATIN AMERICA
    • 5.5.5 MIDDLE EAST & AFRICA
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT FROM NEW ENTRANTS
    • 5.6.2 BARGAINING POWER OF SUPPLIERS
    • 5.6.3 BARGAINING POWER OF BUYERS
    • 5.6.4 INTENSITY OF COMPETITIVE RIVALRY
    • 5.6.5 THREAT FROM SUBSTITUTES
  • 5.7 SUPPLY CHAIN ANALYSIS
    • FIGURE 24 DIRECT DISTRIBUTION-PREFERRED STRATEGY OF PROMINENT COMPANIES
  • 5.8 VALUE CHAIN ANALYSIS
    • FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.9 ECOSYSTEM ANALYSIS
    • FIGURE 26 ENDOSCOPE REPROCESSING MARKET: ECOSYSTEM ANALYSIS
    • 5.9.1 ROLE IN ECOSYSTEM
    • FIGURE 27 KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET ECOSYSTEM
  • 5.10 TECHNOLOGY ANALYSIS
  • 5.11 KEY CONFERENCES & EVENTS IN 2022-2023
    • TABLE 5 ENDOSCOPE REPROCESSING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.12 PATENT ANALYSIS
    • 5.12.1 PATENT GRANTED TRENDS FOR ENDOSCOPE REPROCESSORS
    • FIGURE 28 PATENT GRANTED TRENDS OF AUTOMATED ENDOSCOPE REPROCESSORS, JANUARY 2011- APRIL 2022
    • FIGURE 29 PATENT GRANTED TRENDS OF HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011- FEBRUARY 2022
    • FIGURE 30 PATENT GRANTED TRENDS OF ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011- APRIL 2022
    • 5.12.2 JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR AUTOMATED ENDOSCOPE REPROCESSORS PATENTS, JANUARY 2011-APRIL 2022
    • FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011-APRIL 2022
    • FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011- APRIL 2022
  • 5.13 TRADE ANALYSIS
    • 5.13.1 IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016-2021 (USD MILLION)
    • 5.13.2 EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016-2021 (USD MILLION)
    • 5.13.3 EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016-2021
    • 5.13.4 IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016-2021
  • 5.14 PRICING ANALYSIS
    • TABLE 6 AVERAGE SELLING PRICES OF ENDOSCOPE REPROCESSING EQUIPMENT
    • TABLE 7 AVERAGE SELLING PRICE FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY COUNTRY
    • TABLE 8 COST OF CONSUMABLES INVOLVED IN REPROCESSING ENDOSCOPES WITH MANUAL CLEANING PLUS AER
    • TABLE 9 TOTAL ESTIMATED COST FOR REPROCESSING ONE FLEXIBLE ENDOSCOPE
  • 5.15 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 34 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS
    • TABLE 10 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS (%)
    • 5.15.2 BUYING CRITERIA
    • FIGURE 35 KEY BUYING CRITERIA FOR END USERS
    • TABLE 11 KEY BUYING CRITERIA FOR END USERS
  • 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.16.1 REVENUE SHIFT & REVENUE POCKETS FOR ENDOSCOPE REPROCESSING MANUFACTURERS
    • FIGURE 36 REVENUE SHIFT FOR ENDOSCOPE REPROCESSING

6 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 12 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 13 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
  • 6.2 HIGH-LEVEL DISINFECTANTS AND TEST STRIPS
    • 6.2.1 OUTBREAK OF INFECTIOUS DISEASES TO DRIVE HIGH-LEVEL DISINFECTANTS AND TEST STRIPS DEMAND
    • TABLE 14 ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 15 ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2021-2027 (USD MILLION)
  • 6.3 DETERGENTS & WIPES
    • 6.3.1 INCREASING EMPHASIS ON PRE-CLEANING METHODS TO PROPEL SEGMENT GROWTH
    • TABLE 16 ENDOSCOPE REPROCESSING MARKET DETERGENTS & WIPES, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 17 ENDOSCOPE REPROCESSING MARKET FOR DETERGENTS & WIPES, BY REGION, 2021-2027 (USD MILLION)
  • 6.4 AUTOMATED ENDOSCOPE REPROCESSORS
    • 6.4.1 INCREASED EFFICIENCY OF AUTOMATED ENDOSCOPE REPROCESSORS OVER MANUAL CLEANING TO DRIVE MARKET GROWTH
    • TABLE 18 MANUFACTURERS AND RESPECTIVE AUTOMATED ENDOSCOPE REPROCESSOR MODELS
    • TABLE 19 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 20 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2021-2027 (USD MILLION)
    • 6.4.2 AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY
      • 6.4.2.1 Introduction
    • TABLE 21 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 22 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2021-2027 (USD MILLION)
      • 6.4.2.2 Standalone AER
    • TABLE 23 ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 24 ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2021-2027 (USD MILLION)
      • 6.4.2.3 Portable AER
    • TABLE 25 ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 26 ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2021-2027 (USD MILLION)
    • 6.4.3 AUTOMATED ENDOSCOPE REPROCESSORS, BY TYPE
    • TABLE 27 ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 28 ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE, 2021-2027 (USD MILLION)
      • 6.4.3.1 Single-basin AER
    • TABLE 29 MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (SINGLE BASIN)
      • 6.4.3.2 Double-basin AER
    • TABLE 30 MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (DUAL BASIN)
  • 6.5 ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS
    • 6.5.1 GUIDELINES FOR DRYING, STORAGE, AND TRANSPORTATION OF REPROCESSED ENDOSCOPES TO DRIVE MARKET GROWTH
    • TABLE 31 ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS OFFERED
    • TABLE 32 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 33 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2021-2027 (USD MILLION)
  • 6.6 ENDOSCOPE TRACKING SYSTEMS
    • 6.6.1 RISING FOCUS ON REPROCESSING TO DRIVE SEGMENT GROWTH
    • TABLE 34 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 35 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2021-2027 (USD MILLION)
  • 6.7 OTHER PRODUCTS
    • TABLE 36 OTHER PRODUCTS OFFERED BY MANUFACTURERS
    • TABLE 37 ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 38 ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS, BY REGION, 2021-2027 (USD MILLION)

7 ENDOSCOPE REPROCESSING MARKET, BY END USER

  • 7.1 INTRODUCTION
    • TABLE 39 ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 40 ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
  • 7.2 HOSPITALS
    • 7.2.1 LARGE PATIENT VOLUME IN HOSPITALS TO INCREASE DEMAND FOR ENDOSCOPE REPROCESSING PRODUCTS
    • TABLE 41 ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 42 ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION, 2021-2027 (USD MILLION)
  • 7.3 AMBULATORY SURGERY CENTERS AND CLINICS
    • 7.3.1 COST-EFFECTIVENESS OF AMBULATORY SURGERY CENTERS AND CLINICS TO DRIVE MARKET GROWTH
    • TABLE 43 NUMBER OF MEDICARE-CERTIFIED AMBULATORY SURGERY CENTERS IN US, 2013-2017
    • TABLE 44 TOTAL AMBULATORY SURGERY CENTER PROCEDURES IN US, 2015-2021
    • TABLE 45 ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 46 ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2021-2027 (USD MILLION)
  • 7.4 OTHER END USERS
    • TABLE 47 ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 48 ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY REGION, 2021-2027 (USD MILLION)

8 ENDOSCOPE REPROCESSING MARKET, BY REGION

  • 8.1 INTRODUCTION
    • TABLE 49 ENDOSCOPE REPROCESSING MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 50 ENDOSCOPE REPROCESSING MARKET, BY REGION, 2021-2027 (USD MILLION)
  • 8.2 NORTH AMERICA
    • FIGURE 37 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET SNAPSHOT
    • TABLE 51 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 52 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2021-2027 (USD MILLION)
    • TABLE 53 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 54 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 55 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 56 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 57 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 58 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.2.1 US
      • 8.2.1.1 Favorable reimbursement scenario to propel market growth
    • TABLE 59 MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2021
    • TABLE 60 US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 61 US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 62 US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 63 US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 64 US: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 65 US: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.2.2 CANADA
      • 8.2.2.1 High prevalence of hospital-acquired infections to drive market growth
    • TABLE 66 CANADA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 67 CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 68 CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 69 CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 70 CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 71 CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 72 CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
  • 8.3 EUROPE
    • TABLE 73 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 74 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2021-2027 (USD MILLION)
    • TABLE 75 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 76 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 77 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 78 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 79 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 80 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.3.1 GERMANY
      • 8.3.1.1 Increased surgical procedures to propel market growth
    • TABLE 81 GERMANY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 82 GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 83 GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 84 GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 85 GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 86 GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 87 GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.3.2 UK
      • 8.3.2.1 Increasing use of endoscopy procedures to drive market growth
    • FIGURE 38 MEAN PERCENTAGE CHANGE IN ENDOSCOPE PROCEDURE NUMBERS BETWEEN 2017 AND 2019
    • TABLE 88 UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 89 UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 90 UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 91 UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 92 UK: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 93 UK: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.3.3 FRANCE
      • 8.3.3.1 Increasing prevalence of cancer to support market growth
    • TABLE 94 FRANCE: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 95 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 96 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 97 FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 98 FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 99 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 100 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.3.4 ITALY
      • 8.3.4.1 Growing geriatric population to support market growth
    • TABLE 101 ITALY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 102 ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 103 ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 104 ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 105 ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 106 ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 107 ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.3.5 SPAIN
      • 8.3.5.1 Developing healthcare infrastructure to support market growth
    • TABLE 108 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 109 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 110 SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 111 SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 112 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 113 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.3.6 REST OF EUROPE
    • TABLE 114 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 115 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 116 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 117 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 118 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 119 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
  • 8.4 ASIA PACIFIC
    • FIGURE 39 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SNAPSHOT
    • TABLE 120 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2021-2027 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 123 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 124 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 126 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.4.1 JAPAN
      • 8.4.1.1 Increasing use of endoscopes to drive market growth
    • TABLE 128 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 129 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 130 JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 131 JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 132 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 133 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.4.2 CHINA
      • 8.4.2.1 Rising prevalence of cancer to increase endoscopic procedures
    • TABLE 134 CHINA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 135 CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 136 CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 137 CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 138 CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 139 CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 140 CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.4.3 INDIA
      • 8.4.3.1 Developing healthcare infrastructure to support market growth
    • TABLE 141 INDIA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 142 INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 143 INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 144 INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 145 INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 146 INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 147 INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.4.4 REST OF ASIA PACIFIC
    • TABLE 148 INCIDENCE OF CANCER IN REST OF ASIA PACIFIC COUNTRIES
    • TABLE 149 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 150 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 151 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 152 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 153 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 154 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
  • 8.5 REST OF THE WORLD
    • TABLE 155 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 156 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2021-2027 (USD MILLION)
    • TABLE 157 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 158 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 159 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 160 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 161 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 162 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.5.1 LATIN AMERICA
      • 8.5.1.1 Rising prevalence of infections due to endoscopy-related procedures to support market growth
    • TABLE 163 LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
    • TABLE 164 LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
    • TABLE 165 BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
    • TABLE 166 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 167 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 168 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 169 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 170 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 171 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 8.5.2 MIDDLE EAST & AFRICA
      • 8.5.2.1 Introduction of regulatory frameworks for medical equipment reprocessing to drive market growth
    • TABLE 172 AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 173 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 174 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 175 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017-2020 (USD MILLION)
    • TABLE 176 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021-2027 (USD MILLION)
    • TABLE 177 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 178 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021-2027 (USD MILLION)

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 179 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS
  • 9.3 REVENUE ANALYSIS
    • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET
  • 9.4 MARKET SHARE ANALYSIS
    • FIGURE 41 ENDOSCOPE REPROCESSING MARKET SHARE ANALYSIS, 2020
    • TABLE 180 ENDOSCOPE REPROCESSING MARKET: DEGREE OF COMPETITION
  • 9.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)
    • 9.5.1 STARS
    • 9.5.2 EMERGING LEADERS
    • 9.5.3 PERVASIVE PLAYERS
    • 9.5.4 PARTICIPANTS
    • FIGURE 42 VENDOR DIVE: ENDOSCOPE REPROCESSING MARKET
  • 9.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES)
    • 9.6.1 PROGRESSIVE COMPANIES
    • 9.6.2 STARTING BLOCKS
    • 9.6.3 RESPONSIVE COMPANIES
    • 9.6.4 DYNAMIC COMPANIES
    • FIGURE 43 ENDOSCOPE REPROCESSING MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2020
      • 9.6.4.1 COMPETITIVE BENCHMARKING
    • TABLE 181 ENDOSCOPE REPROCESSING MARKET: DETAILED LIST OF KEY STARTUP/SMES
    • TABLE 182 ENDOSCOPE REPROCESSING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [STARTUPS/SMES]
  • 9.7 COMPANY FOOTPRINT
    • TABLE 183 COMPANY FOOTPRINT
    • TABLE 184 COMPANY PRODUCT FOOTPRINT
    • TABLE 185 COMPANY GEOGRAPHICAL FOOTPRINT
  • 9.8 COMPETITIVE SCENARIO AND TRENDS
    • 9.8.1 DEALS
    • TABLE 186 DEALS, JANUARY 2019- APRIL 2022
    • 9.8.2 PRODUCT LAUNCHES & APPROVALS
    • TABLE 187 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019- APRIL 2022
    • 9.8.3 EXPANSIONS
    • TABLE 188 EXPANSIONS, JANUARY 2019- APRIL 2022

10 COMPANY PROFILES

  • 10.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 10.1.1 CANTEL MEDICAL
    • TABLE 189 CANTEL MEDICAL: BUSINESS OVERVIEW
    • FIGURE 44 CANTEL MEDICAL: COMPANY SNAPSHOT (2020)
    • 10.1.2 ADVANCED STERILIZATION PRODUCTS (FORTIVE)
    • TABLE 190 ADVANCED STERILIZATION PRODUCTS (FORTIVE): BUSINESS OVERVIEW
    • FIGURE 45 ADVANCED STERILIZATION PRODUCTS (FORTIVE): COMPANY SNAPSHOT (2020)
    • 10.1.3 OLYMPUS CORPORATION
    • TABLE 191 OLYMPUS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 46 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020)
    • 10.1.4 ECOLAB
    • TABLE 192 ECOLAB: BUSINESS OVERVIEW
    • FIGURE 47 ECOLAB: COMPANY SNAPSHOT (2021)
    • 10.1.5 STERIS
    • TABLE 193 STERIS: BUSINESS OVERVIEW
    • FIGURE 48 STERIS: COMPANY SNAPSHOT (2020)
    • 10.1.6 GETINGE AB
    • TABLE 194 GETINGE AB: BUSINESS OVERVIEW
    • FIGURE 49 GETINGE AB: COMPANY SNAPSHOT (2021)
    • 10.1.7 WASSENBURG MEDICAL (A MEMBER OF HOYA)
    • TABLE 195 WASSENBURG MEDICAL (A MEMBER OF HOYA): BUSINESS OVERVIEW
    • FIGURE 50 WASSENBURG MEDICAL (A MEMBER OF HOYA): COMPANY SNAPSHOT (2020)
    • 10.1.8 CONMED CORPORATION
    • TABLE 196 CONMED CORPORATION: BUSINESS OVERVIEW
    • FIGURE 51 CONMED CORPORATION: COMPANY SNAPSHOT (2021)
    • 10.1.9 BELIMED AG (A METALL ZUG GROUP COMPANY)
    • TABLE 197 BELIMED AG (METALL ZUG GROUP COMPANY): BUSINESS OVERVIEW
    • FIGURE 52 BELIMED AG (METALL ZUG GROUP COMPANY): COMPANY SNAPSHOT (2021)
    • 10.1.10 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL)
    • TABLE 198 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL): BUSINESS OVERVIEW
    • FIGURE 53 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL): COMPANY SNAPSHOT (2020)
    • 10.1.11 CUSTOM ULTRASONICS
    • TABLE 199 CUSTOM ULTRASONICS: BUSINESS OVERVIEW
    • 10.1.12 STEELCO S.P.A
    • TABLE 200 STEELCO S.P.A: BUSINESS OVERVIEW
    • 10.1.13 BES HEALTHCARE (A DIVISION OF BES REHAB LTD)
    • TABLE 201 BES HEALTHCARE: BUSINESS OVERVIEW
    • 10.1.14 ARC HEALTHCARE SOLUTIONS
    • TABLE 202 ARC HEALTHCARE SOLUTIONS: BUSINESS OVERVIEW
    • 10.1.15 METREX RESEARCH, LLC
    • TABLE 203 METREX RESEARCH. LLC: BUSINESS OVERVIEW
  • 10.2 OTHER PLAYERS
    • 10.2.1 RICHARD WOLF GMBH
    • TABLE 204 RICHARD WOLF GMBH: BUSINESS OVERVIEW
    • 10.2.2 MEDALKAN
    • TABLE 205 MEDALKAN: BUSINESS OVERVIEW
    • 10.2.3 MICRO-SCIENTIFIC, LLC
    • TABLE 206 MICRO-SCIENTIFIC, LLC: BUSINESS OVERVIEW
    • 10.2.4 BORER CHEMIE AG
    • TABLE 207 BORER CHEMIE AG: BUSINESS OVERVIEW
    • 10.2.5 MEDONICA CO. LTD
    • TABLE 208 MEDONICA CO. LTD: BUSINESS OVERVIEW
    • 10.2.6 TUTTNAUER
    • TABLE 209 TUTTNAUER: BUSINESS OVERVIEW
    • 10.2.7 ATMS
    • TABLE 210 ATMS: BUSINESS OVERVIEW
    • 10.2.8 SUMMIT IMAGING, INC.
    • TABLE 211 SUMMIT IMAGING, INC.: BUSINESS OVERVIEW
    • 10.2.9 SHINVA MEDICAL INSTRUMENT CO., LTD
    • TABLE 212 SHINVA MEDICAL INSTRUMENT CO., LTD: BUSINESS OVERVIEW
    • 10.2.10 MEDICAL DEVICES GROUP SRL
    • TABLE 213 MEDICAL DEVICES GROUP SRL: BUSINESS OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

11 APPENDIX

  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3 AVAILABLE CUSTOMIZATIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS